Friday, January 20, 2017 12:45:23 PM
B, C & E are toxic, but if you are not familiar with the D series, below is a refresher from the 9/30/2016 filing with OTC markets. One Preferred D share can be converted into 120,000 DECN common shares. What is going on here folks? Why didn't Berman issue a PR about this? Can someone call Berman and ask?
.....................
Series “D” convertible preferred stock
We have designated 500 shares of our $0.001 preferred stock as 2012 Series “D”. We have not issued any shares of
this issue of Preferred stock. Holders of series “D”: convertible stock shall not have the right to vote on matters that
come before the shareholders. 2012 Series “D” convertible preferred stock may be converted immediately upon
distribution. The number of shares into which one share of 2012 Series “D” Preferred Stock shall be convertible into common stock shares is 1 for 120,000 shares of $0.001 par value common stock. 2012 Series “D” convertible stock
shall rank junior to all other classes of Preferred stock in the event of liquidation. Holders of 2012 Series “D”
convertible stock shall not be entitled to a mandatory monthly dividend.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM